...
首页> 外文期刊>Journal of separation science. >Application and optimization of organic-inorganic hybrid monolithic capillary electrochromatography for in vivo cefdinir determination with microdialysis
【24h】

Application and optimization of organic-inorganic hybrid monolithic capillary electrochromatography for in vivo cefdinir determination with microdialysis

机译:有机-无机混合整体毛细管电色谱法在微透析体内测定头孢地尼中的应用和优化

获取原文
获取原文并翻译 | 示例

摘要

In this study, an organic-inorganic hybrid monolithic capillary column was applied and optimized for the determination of cefdinir in plasma, and the electro-osmotic flow that usually hinders migration in reverse polarity became a driving force. The Sample used for pharmacokinetic research was collected by microdialysis using phosphate buffer (pH 7.4) as perfusate, and a volume of 60 mu L fluid was mixed with 140 mu L of acetonitrile. By using a silica-allyldimethyldodecylammonium monolithic column (100 mu m inner diameter, 21 cm effective length and 31.2 cm total length), and a mobile phase consisting of phosphate and acetonitrile (pH 4.5, 50: 50, v/v), at a voltage of 20 kV, the analytes were successfully separated with the background within 2.5 min. The detection wavelength was 214 nm. The calibration curve showed a good linearity (r(2) = 0.9994) over the concentration range of 0.2-50 mu g/mL. The proposed method showed good specificity, linearity, sensitivity, precision and recovery, and the introduction of field amplified sample stacking helped to improve the low recovery caused by microdialysis. This method was successfully applied to quantify cefdinir in rat plasma to support a pre-clinical pharmacokinetic trial.
机译:在这项研究中,有机-无机混合整体毛细管柱被应用并优化了血浆中头孢地尼的测定,通常阻碍反极性迁移的电渗流成为驱动力。使用磷酸盐缓冲液(pH 7.4)作为灌注液,通过微渗析收集用于药物动力学研究的样品,然后将体积为60μL的液体与140μL的乙腈混合。通过使用硅胶-烯丙基二甲基十二烷基铵整体柱(内径100μm,有效长度21 cm,总长度31.2 cm)以及由磷酸盐和乙腈组成的流动相(pH 4.5,50:50,v / v)在20 kV的高压下,分析物在2.5分钟内成功地与背景分离。检测波长为214nm。校准曲线在0.2-50μg / mL的浓度范围内显示出良好的线性(r(2)= 0.9994)。所提出的方法显示出良好的特异性,线性,灵敏度,精密度和回收率,引入现场扩增样品堆叠技术有助于改善微透析引起的低回收率。此方法已成功应用于定量大鼠血浆中的头孢地尼,以支持临床前药代动力学试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号